ストックスクリーナーアプリを入手
13.76
0.79%
-0.15
Lensar Inc (LNSR) 最新ニュース
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, TURN, DNB, GB on Behalf of Shareholders - GlobeNewswire Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (NasdaqLNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSEDNB), Global Blue Group Holding AG (N - TradingView
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Is LENSAR (LNSR) a Deeply Undervalued Stock? - Insider Monkey
Trading (LNSR) With Integrated Risk Controls - news.stocktradersdaily.com
Taxation With Representation: Norton Rose, Latham, Ashurst - Law360
Lake Street Capital Reiterates "Hold" Rating for LENSAR (NASDAQ:LNSR) - MarketBeat
Alcon Inc’s Acquisition of LENSAR Inc - Global Legal Chronicle
Related Content: Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics Spectra
Alcon to buy Lensar in deal worth up to $430M - The Business Journals
Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics Spectra
ALC Stock Rises Following the Merger Agreement With LENSAR - MSN
Alcon signs merger agreement to acquire Lensar - MSN
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc.LNSR - Business Wire
Bernstein maintains Alcon Outperform rating, $110.50 target By Investing.com - Investing.com UK
Alcon lines up Lensar deal to expand laser cataract surgery options - Optics.org
BTIG Research Downgrades LENSAR to Neutral From Buy - MarketScreener
Alcon agrees to purchase LENSAR - Ophthalmology Times
Switzerland: Alcon agrees acquisition of Lensar for up to US$430m - Investors in Healthcare
LENSAR’s (LNSR) “Hold” Rating Reaffirmed at Lake Street Capital - Defense World
Alcon Agrees to Acquire Lensar, Inc. for Up to $430 Million - VisionMonday.com
BTIG cuts LENSAR stock rating post Alcon acquisition deal - Investing.com India
BTIG cuts LENSAR stock rating post Alcon acquisition deal By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc.LNSR - The Malaysian Reserve
Latham & Watkins Represents LENSAR, Inc. in Acquisition by Alcon - Latham & Watkins LLP
Alcon to Acquire LENSAR in $430M Deal - USA Herald
Alcon to acquire Lensar for up to $430M - BioWorld MedTech
Norton Rose, Latham Steer Alcon's $430M Lensar Buy - Law360
Alcon agrees to acquire LENSAR for $14.00 per share - MSN
Alcon to acquire LENSAR for up to $430 million By Investing.com - Investing.com South Africa
Alcon to Acquire Lensar for up to $430 million. - MD+DI
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of LENSAR, Inc. (LNSR) - TradingView
Alcon Agrees to Acquire LENSAR, Inc. - sharewise.com
Alcon Buys MedTech Company LENSAR - themiddlemarket.com
Lake Street Downgrades LENSAR to Hold From Buy, Price Target is $15 -March 24, 2025 at 11:54 am EDT - Marketscreener.com
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - Benzinga
Switzerland's Alcon to Buy US-based Medical Technology Group Lensar -March 24, 2025 at 09:48 am EDT - Marketscreener.com
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire
LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders - Bluefield Daily Telegraph
Alcon to Buy Lensar for up to $430 Million - MPO-mag
Alcon to Acquire Lensar for $430 Million -March 24, 2025 at 08:42 am EDT - Marketscreener.com
Alcon to acquire LENSAR for up to $430 million - Investing.com
LENSAR Announces Merger Agreement with Alcon - TipRanks
Alcon Agrees To Acquire LENSAR For Up To Approximately $430 Mln - Nasdaq
Alcon Agrees To Acquire Lensar, Inc. -March 24, 2025 at 08:03 am EDT - MarketScreener
Major Medical Tech Deal: Alcon Acquires Robotic Surgery Pioneer LENSAR for $430M - Stock Titan
LENSAR, Inc. (NASDAQ:LNSR) Shares Purchased by Atria Investments Inc - Defense World
LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU - Business Wire
0.81%
1.34%
大文字化:
|
ボリューム (24 時間):